Abstract
The potential biomedical application of carbon nanotubes (CNTs) pertinent to drug delivery is highly manifested considering the remarkable electronic and structural properties exhibited by CNT. To simulate the interaction of nanomaterials with biomolecular systems, we have performed density functional calculations on the interaction of pyrazinamide (PZA) drug with functionalized single-wall CNT (fSWCNT) as a function of nanotube chirality and length using two different approaches of covalent functionalization, followed by docking simulation of fSWCNT with pncA protein. The functionalization of pristine SWCNT facilitates in enhancing the reactivity of the nanotubes and formation of such type of nanotube-drug conjugate is thermodynamically feasible. Docking studies predict the plausible binding mechanism and suggests that PZA loaded fSWCNT facilitates in the target specific binding of PZA within the protein following a lock and key mechanism. Interestingly, no major structural deformation in the protein was observed after binding with CNT and the interaction between ligand and receptor is mainly hydrophobic in nature. We anticipate that these findings may provide new routes towards the drug delivery mechanism by CNTs with long term practical implications in tuberculosis chemotherapy.












Similar content being viewed by others
References
Reich S, Thomsen C, Maultzsch J (2004) Carbon nanotubes: basic concepts and physical properties. Wiley-VCH, Weinheim 215
Challa SS, Kumar R, Hormes J, Leuschner C (2005) Nanofabrication towards biomedical applications, techniques, tools, applications and impact. Wiley-VCH, Weinheim, pp 236–289
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171
Kam NWS, Liu Z, Dai H (2006) Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed 45:577–581
Liu Y, Wu D-C, Zhang W-D, Jiang X, He C-B, Chung TS, Goh SH, Leong KW (2005) Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed 44(30):4782–4785
Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ (2008) Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc 130(34):11467–11476
Kam NWS, Liu Z, Dai H (2005) Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 127(36):12492–12493
Smith DA, van de Waterbeemd H (1999) Pharmacokinetics and metabolism in early drug discovery. Curr Opin Chem Biol 3(4):373–378
Besteman K, Lee JO, Wiertz FGM, Herring HA, Dekker C (2003) Enzyme-coated carbon nanotubes as single-molecule biosensors. Nano Lett 3(6):727–730
Chen X, Tam UC, Czlapinski JL, Lee GS, Rabuka D, Zettl A, Bertozzi CR (2006) Interfacing carbon nanotubes with living cells. J Am Chem Soc 128(19):6292–6293
Kang Y, Wang Q, Liu YC, Shen JW, Wu T (2010) Diameter selectivity of protein encapsulation in carbon nanotubes. J Phys Chem B 114(8):2869–2875
Bianco A, Kostarelos K, Partidos CD, Prato M (2005) Biomedical applications of functionalised carbon nanotubes. M Chem Commun 5:571–577
Lacerda L, Bianco A, Prato M, Kostarelos K (2006) Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Del Rev 58(14):1460–1470
Bianco A, Hoebeke J, Godefroy S, Chaloin O, Pantarotto D, Briand JP, Muller S, Prato CD (2005) Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. J Am Chem Soc 127(1):58–59
Chełmecka E, Pasterny K, Kupka T, Stobiński L (2012) DFT studies of COOH tip-functionalized zigzag and armchair single wall carbon nanotubes. J Mol Model 18(5):2241–2246
Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand J-P, Gennaro R, Prato M, Bianco A (2005) Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed 44(39):6358–6362
Liu Z, Sun X, Nakayama-Ratchford N, Dai H (2007) Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 1(1):50–57
Bianco A, Kostarelos K, Partidos CD, Prato M (2005) Biomedical applications of functionalised carbon nanotubes. Chem Commun 5:571–577
Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, Cheng HKF, Li L, Tan LP (2011) Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem Commun 47(18):5235–5237
Nimmagadda A, Thurston K, Nollert MU, McFetridge PS (2006) Chemical modification of SWNT alters in vitro cell-SWNT interactions. J Biomed Mater Res Part A 76A:614–625
Murugesan S, Park TJ, Yang H, Mousa S, Linhardt RJ (2006) Blood compatible carbon nanotubes-nano-based neoproteoglycans. Langmuir 22(8):3461–3463
Zhang L, Xia J, Zhao Q, Liu L, Zhang Z (2010) Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6(4):537–544
Wu W, Li R, Bian X, Zhu Z, Ding D, Li X, Jia Z, Jiang X, Hu Y (2009) Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. ACS Nano 3(9):2740–2750
Saikia N, Deka RC (2011) Density functional calculations on adsorption of 2-methylheptylisonicotinate antitubercular drug onto functionalized carbon nanotube. Comput Theor Chem 964:257–261
Saikia N, Pati SK, Deka RC (2012) First principles calculation on the structure and electronic properties of BNNTs functionalized with isoniazid drug molecule. Appl Nanosci. doi:10.1007/s13204-012-0124-6
Murakami T, Fan J, Yudasaka M, Iijima S, Shiba K (2006) Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate. Mol Pharm 3(4):407–414
Popov AM, Lozovik YE, Fiorito S, Yahia L (2007) Biocompatibility and applications of carbon nanotubes in medical nanorobots. Int J Nanomed 2:361–372
Sung J, Barone PW, Kong H, Strano MS (2009) Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors. Biomaterials 30(4):622–631
Ali-Boucetta H, Al-Jamal KT, McCarthy D, Prato M, Bianco A, Kostarelos K (2008) Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 4:459–461
Pastorin G, Wu W, Wieckowski S, Briand JP, Kostarelos K, Prato M, Bianco A (2006) Double functionalisation of carbon nanotubes for multimodal drug delivery. Chem Commun 21:1182–1184
Zanella I, Fagan SB, Mota R, Fazzio A (2007) Ab initio study of pristine and Si-doped capped carbon nanotubes interacting with nimesulide molecules. Chem Phys Lett 439:348–353
Liu Z, Winters M, Holodniy M, Dai H (2007) siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed 46(12):2023–2027
Zerda ADL, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ, Oralkan O, Cheng Z, Chen X, Dai H, Khuri-Yakub BT, Gambhir SS (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 3(9):557–562
Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H (2007) In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2(1):47–52
Cole ST, Eisenach KD, McMurray DN, Jacobs WR Jr (eds) (2005) Tuberculosis and the tubercle bacillus. ASM Press, Washington
Maher D, Chaulet P, Spinaci S, Harries A (1997) Treatment of tuberculosis: guidelines for national programmes. Wold Health Organization, Geneva
Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W (2011) Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. PLoS ONE 6:e15785. doi:10.1371/journal.pone.0015785
Konno K, Feldmann FM, McDermott W (1967) Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respipr Dis 95(3):461–469
Scorpio A, Zhang Y (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2(6):662–667
Sheen P, Ferrer P, Gilman RH, Llano JL, Fuentes P, Valencia E, Zimic MJ (2009) Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis 89(2):109–113
Du X, Wang W, Kim R, Yakota H, Nguyen H, Kim SH (2001) Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochem 40(47):14166–14172
Lemaitre N, Callebaut I, Frenois F, Jarlier V, Sougakoff W (2001) Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis. Biochem J 353:453–458
Gallo M, Favila A, Glossman-Mitnik D (2007) DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chem Phys Lett 447(1–3):105–109
Saikia N, Deka RC (2010) Theoretical study on pyrazinamide adsorption onto covalently functionalized (5,5) metallic single-walled carbon nanotube. Chem Phys Lett 500(1–3):65–70
Saikia N, Deka RC (2012) A comparison of the effect of nanotube chirality and electronic properties on the π–π interaction of single-wall carbon nanotubes with pyrazinamide antitubercular drug. Int J Quant Chem. doi:10.1002/qua.24275
Georgakilas V, Kordatos K, Prato M, Guldi DM, Holzinger M, Hirsch A (2002) Organic functionalization of carbon nanotubes. J Am Chem Soc 124(5):760–761
Lu X, Tian F, Xu X, Wang N, Zhang Q (2003) Theoretical exploration of the 1,3-dipolar cycloadditions onto the sidewalls of (n, n) armchair single-wall carbon nanotubes. J Am Chem Soc 125(34):10459–10464
Yao Z, Braidy N, Botton GA, Adronov A (2003) Polymerization from the surface of single-walled carbon nanotubes-preparation and characterization of nanocomposites. J Am Chem Soc 125(51):16015–16024
Hirsch A, Vostrowsky O (2005) Functionalization of carbon nanotubes. Top Curr Chem 245:193–237
Delley B (1990) An all-electron numerical method for solving the local density functional for polyatomic molecules. J Chem Phys 92:508–517
Perdew JP, Wang Y (1992) Accurate and simple analytic representation of the electron-gas correlation energy. Phys Rev B 45:13244–13249
Pauling L (1960) The nature of chemical bond. Cornell University Press, Ithaca
Pearson RG (1963) Hard and soft acids and bases. J Am Chem Soc 85:3533–3539
Pearson RG (1997) Chemical hardness: applications from molecules to solids. Wiley-VCH GMBH, Weinheim
Mulliken RS (1934) Electronic structures of molecules. XI. Electroaffinity, molecular orbitals and dipole moments. J Chem Phys 2:782–793
Seal A, Aykkal R, Babu RO, Ghosh M (2011) Docking study of HIV-1 reverse transcriptase with phytochemicals. Bioinformation 5(10):430–439
Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49(11):3315–3321
Storn R, Price K (1995) Differential evolution—a simple and efficient adaptive scheme for global optimization over continuous spaces; technical report. International Computer Science Institute, Berkley
Yang JM, Chen CC (2004) GEMDOCK: a generic evolutionary method for molecular docking. Proteins 55(2):288–304
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14):1639–1662
Lu X, Tian F, Xu X, Wang N, Zhang Q (2003) A theoretical exploration of the 1,3-dipolar cycloadditions onto the sidewalls of (n, n) armchair single-wall carbon nanotubes. J Am Chem Soc 125(34):10459–10464
Girifalco LA, Hodak M (2002) Van der Waals binding energies in graphitic structures. Phys Rev B 65(125404):1–5
Borstnik U, Hodoscek M, Janezic D, Lukovits I (2005) Electronic structure properties of carbon nanotubes obtained by density functional calculations. Chem Phys Lett 411(4–6):384–388
Unissa AN, Selvakumar N, Hassan S (2009) Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking. Bioinformation 4(1):24–29
Scorpio A, Zhang Y (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2:662–667
Zhang H, Deng JY, Bi LJ, Zhou YF, Zhang ZP, Zhang CG, Zhang Y, Zhang XE (2008) Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. FEBS J 275(4):753–762
Prentis RA, Lis Y, Walker SR (1988) Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985). Br J Clin Pharmac 25(3):387–396
Egan WJ, Merz KM Jr, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43(21):3867–3877
Ghose AK, Viswanadhan VN, Wendoloski JJ (1998) Prediction of hydrophobic (Lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem 102:3762–3770
Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherborne B, Cooper I, Platts JA (2001) Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J Pharm Sci 90(6):749–784
Yee S (1997) In vitro permeability across Caco-2 cells (Colonic) can predict in vivo (small intestinal) absorption in man—fact or myth. Pharm Res 14(6):763–766
Bemis GW, Murcko MA (1992) Designing libraries with CNS activity. J Med Chem 42(24):4942–4951
Yazdanian M, Glynn SL, Wright JL, Hawi A (1998) Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res 15(9):1490–1494
Acknowledgments
This work is supported by the funding from the Department of Science and Technology (DST), New Delhi, India.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Saikia, N., Rajkhowa, S. & Deka, R.C. Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein. J Comput Aided Mol Des 27, 257–276 (2013). https://doi.org/10.1007/s10822-013-9638-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-013-9638-6